Global Immunoprecipitation Market to value over USD 1.19 billion and register a CAGR of over 6.02% during the forecast period, 2025 to 2033.

 Immunoprecipitation finds wide applications in the medical industry. They are also heavily employed in the research of various applications such as targeted protein purification, protein concentration, analysis of protein-protein interactions, identification or analysis of protein complexes, and analysis of protein or DNA. WIth rising activities in the research sector and advancements in the life sciences industry, the global immunoprecipitation market is forecasted to bolster during the projected time frame. There is an upsurge and rising need for quick and accurate diagnosis and identification of antigens associated with autoimmune diseases through antigen-antibody interaction which thus creates opportunities on a global scale for the expansion of immunoprecipitation market size. This is vital in understanding disease mechanisms and developing effective and relevant drugs targeting these diseases. Therefore, with rising consciousness, the need for these services is rising and is expected to accelerate the CAGR of the market during the forecast period.

Based on type, the immunoprecipitation market is segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation and RNA immunoprecipitation. The individual immunoprecipitation segment is predicted to attain the largest immunoprecipitation market share and grow at the fastest CAGR during the projected time frame.

The increasing use of immunoprecipitation in the research of protein-protein interactions, antigen diagnosis, and to determine the relative quantity of an antigen are the driving factors for segment growth in various research studies during the forecast period.

By product type, the market is segmented into kits, reagents and accessories. The segment of kits is projected to grow at the fastest CAGR in the immunoprecipitation market during the forecast period. Growth in this market can be attributed to factors such as the requirement for the repurchase of kits coupled with the increasing number of IP assays to isolate and purify antigens.

Key Drivers of Market Growth

The immunoprecipitation (IP) market is experiencing significant expansion, propelled by several critical factors:

  • Surge in Proteomics and Genomics Research: The escalating demand for protein isolation and analysis in proteomics and genomics studies is a primary driver. Immunoprecipitation techniques are pivotal in identifying protein-protein interactions, post-translational modifications, and chromatin-associated proteins.
  • Advancements in Personalized Medicine: The shift towards personalized therapeutics necessitates precise biomarker identification and validation, where IP plays a crucial role in isolating specific proteins and nucleic acids.
  • Technological Innovations: The development of automated and high-throughput IP systems has enhanced reproducibility and efficiency, catering to the growing needs of research institutions and pharmaceutical companies.

Global Immunoprecipitation Market Segmentation:

By Type

  • Individual Immunoprecipitation
  • Co-Immunoprecipitation
  • Chromatin Immunoprecipitation
  • RNA Immunoprecipitation

By Product

  • Kits
  • Reagents
    • Antibodies
      • Primary Antibodies
      • Secondary Antibodies
    • Beads
      • Agarose Beads
      • Magnetic Beads
      • Buffers
  • Accessories

By End-User

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period, fueled by increasing investments in biotechnology research, government initiatives, and a growing focus on personalized medicine. North America is projected to maintain a significant market share, supported by the presence of key industry players and advanced research infrastructure.

Major key players included in the Immunoprecipitation Market:

  • Thermo Fisher Scientific
  • Abcam
  • Bio-Rad Laboratories
  • Merck KGaA
  • GenScript
  • Takara Bio
  • Rockland Immunochemicals
  • Geno Technology
  • Biolegend
  • Cell Signaling Technology

Recent Developments by Leading Companies

Thermo Fisher Scientific: In 2022, the company launched the Pierce Magnetic IP/Co-IP Kit, a user-friendly and high-performance solution for immunoprecipitation experiments. Additionally, Thermo Fisher introduced the Metrios 6 Scanning Transmission Electron Microscope in June 2023, enhancing productivity and data quality in high-volume semiconductor manufacturing. 

Abcam: In November 2023, Abcam was acquired by Danaher Corporation, which gained access to Abcam’s extensive product offerings and customer base, thereby enhancing Danaher's position as a leading provider of solutions for life science research. 

Bio-Rad Laboratories: In 2020, Bio-Rad expanded its portfolio of IP-specific antibodies and kits, addressing the growing demand for advanced proteomics research tools. 

Merck KGaA: In May 2024, Merck announced its intention to acquire Mirus Bio, a US-based life science company, aiming to expand its presence in the life sciences sector and strengthen its capabilities in gene delivery and gene expression technologies. 

GenScript Biotech Corporation: In September 2023, GenScript expanded its IVT mRNA synthesis portfolio with the addition of customized circular RNA (circRNA) and lipid nanoparticles (LNPs) formulation services, advancing research in fields such as vaccine development, protein replacement therapies, and gene and cell therapy.

Objectives of the Study:

  • To provide an exhaustive analysis of the Global Immunoprecipitation Market By Type, By Product, By End-User, and By Region
  • To provide comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, the Middle East and Africa
  • To record, evaluate, and competitive landscape mapping- product launches, technological advancements, mergers, and expansions Profiling of companies to assess their market shares, strategies, financial and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com